Adenylyl cyclase 3 haploinsufficiency confers susceptibility to diet-induced obesity and insulin resistance in mice.
Adenylyl cyclase 3 (Adcy3), a member of the mammalian adenylyl cyclase family responsible for generating the second messenger cAMP, has long been known to play an essential role in olfactory signal transduction. Here, we demonstrated that Adcy3 heterozygous null mice displayed increased visceral adiposity in the absence of hyperphagia and developed abnormal metabolic features characterized by impaired insulin sensitivity, dyslipidemia, and increased plasma levels of proinflammatory cytokines on both chow and high-fat diet (HFD). Of note, HFD decreased the Adcy3 expression in white adipose tissue, liver, and muscle. We also report for the first time that Adcy3 haploinsufficiency resulted in reduced expression of genes involved in thermogenesis, fatty acid oxidation, and insulin signaling, with enhanced expression of genes related to adipogenesis in peripheral tissues of mice. In conclusion, these findings suggest that cAMP signals generated by Adcy3 in peripheral tissues may play a pivotal role in modulating obesity and insulin sensitivity.
Department of Food and Nutrition, Brain Korea 21 PLUS Project, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, South Korea.
Tao
T
Tong
Department of Food and Nutrition, Brain Korea 21 PLUS Project, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, South Korea.
Ying
Y
Shen
Department of Biochemistry, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, South Korea.
Han-Woong
HW
Lee
Department of Food Science and Nutrition, University of Ulsan, Mugeo-dong, Nam-ku, Ulsan 680-749, South Korea.
Rina
R
Yu
Department of Food and Nutrition, Brain Korea 21 PLUS Project, Yonsei University, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-749, South Korea.
Taesun
T
Park
Am J Physiol. 1996 Apr;270(4 Pt 2):R755-60
8967404
Am J Physiol Gastrointest Liver Physiol. 2008 Oct;295(4):G725-34
18687752
PLoS One. 2009 Sep 11;4(9):e6979
19750222
FASEB J. 2010 Nov;24(11):4229-39
20667975
Horm Metab Res. 2014 Nov;46(12):833-40
25247872
Annu Rev Physiol. 2010;72:219-46
20148674
J Biol Chem. 2003 Nov 14;278(46):45777-84
12952969
Nutr Diabetes. 2016 Jan 25;6:e191
26807509
J Biol Chem. 2003 Oct 31;278(44):43074-80
12941946
Neuron. 2000 Sep;27(3):487-97
11055432
Dev Cell. 2009 Nov;17(5):649-61
19922870
Cell Signal. 2006 Apr;18(4):401-8
16182514
Am J Physiol. 1998 Jun;274(6 Pt 1):C1674-85
9611134
Biochem Biophys Res Commun. 2001 Sep 7;286(5):852-6
11527376
FASEB J. 2010 Aug;24(8):2859-68
20371630
Mol Pharmacol. 2003 Mar;63(3):463-8
12606751
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2059-64
19174512
PLoS One. 2014 Oct 16;9(10):e110226
25329148
Nat Neurosci. 2002 Aug;5(8):727-8
12101402
Biochem J. 2003 Nov 1;375(Pt 3):517-29
12940771
J Biol Chem. 2010 Apr 23;285(17):12504-11
20157112
Ann N Y Acad Sci. 2010 Mar;1190:1-14
20388132
Islets. 2012 Sep-Oct;4(5):343-8
23018249
Annu Rev Pharmacol Toxicol. 2001;41:145-74
11264454
J Biol Chem. 1957 May;226(1):497-509
13428781
Am J Physiol Renal Physiol. 2009 Jan;296(1):F87-97
18945824
PLoS One. 2010 Nov 04;5(11):e13851
21079816
Mol Cell Biol. 2004 Apr;24(7):3057-67
15024092
EMBO J. 2010 Jan 20;29(2):469-81
19942859
Int J Obes (Lond). 2008 Mar;32(3):407-12
17895882
Endocrinology. 1998 May;139(5):2588-99
9564875
Curr Top Dev Biol. 2005;67:207-24
15949535
Mol Endocrinol. 2005 May;19(5):1277-90
15705663